Pharming (PHAR) Revenue Growth (1y) (2021 - 2026)
Pharming (PHAR) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | - |
| 4 | BeOne Medicines | 471.45 Bn | 466.66 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 122.00 Bn | 114.75 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.99 Bn | 61.23 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.67 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 96.43% |
| 10 | Pharming | 8.96 Bn | 8.91 Bn | 65.80 Mn | 91,595,975.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91,595,975.56% |
| Dec 31, 2025 | -47.92% |
| Sep 30, 2025 | 130,080,113.90% |
| Jun 30, 2025 | -100.00% |
| Mar 31, 2025 | 42.29% |
| Dec 31, 2024 | 151.85% |
| Sep 30, 2024 | -100.00% |
| Jun 30, 2024 | 33.09% |
| Mar 31, 2024 | -100.00% |
| Dec 31, 2023 | -100.00% |
| Sep 30, 2023 | 22.99% |
| Jun 30, 2023 | 94.49% |
| Mar 31, 2023 | -8.71% |
| Dec 31, 2022 | 208.40% |
| Sep 30, 2022 | 2.98% |
| Jun 30, 2022 | 0.93% |
| Mar 31, 2022 | 6.88% |
| Dec 31, 2021 | -242.43% |
| Sep 30, 2021 | -2.30% |